Crataegus laevigata decreases neutrophil elastase and has hypolipidemic effect: A randomized, double-blind, placebo-controlled trial

Phytomedicine

Volumn 18, Issue 8-9, 2011, Pages 769-775

  Dalli, E ^a   Colomer, E ^a   Tormos, M C ^b   Cosin Sales J ^a   Milara, J ^b   Esteban, E ^a   Saez G ^b  

^a HOSPITAL ARNAU DE VILANOVA   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Coronary heart disease; Crataegus laevigata (Rosaceae); Elastase; Neutrophil function; Randomized, double blind placebo controlled trial

Indexed keywords

ANTILIPEMIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CRATAEGUS EXTRACT; CRATAEGUS LAEVIGATA EXTRACT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LEUKOCYTE ELASTASE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; PLACEBO; PLANT EXTRACT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CRATAEGUS; CRATAEGUS LAEVIGATA; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; FLOWER; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOLIPEMIA; ISCHEMIC HEART DISEASE; MALE; MEDICINAL PLANT; NONHUMAN; PLANT LEAF; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE;

AGED; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; CORONARY DISEASE; CRATAEGUS; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FLOWERS; HUMANS; LEUKOCYTE ELASTASE; LIPID PEROXIDATION; MIDDLE AGED; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES;

CRATAEGUS LAEVIGATA; ROSACEAE;

EID: 79958092564     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2010.11.011     Document Type: Article

References (54)

1. 2 inhibition. J. Pharm. Pharmacol. 49, 329-331.
2. Allain, C.C., Poon, L.S., Chan, C.S., Richmond, W., Fu, P.C., 1974. Enzymatic determination of total cholesterol in serum. Clin. Chem. 20, 470-475.
3. Al Makdessi, S., Sweidan, H., Müllner, S., Jacob, R., 1996. Myocardial protection by pre-treatment with Crataegus oxyacantha. An assessment by means of the release of lactate dehydrogenase by the ischemic and reperfused Langendorff heart. Arzneimittelforsch. Drug Res. 46, 25-27.
4. Al Makdessi, Sweidan, H., Dietz, K., Jacob, R., 1999. Protective effect of Crataegus oxyacantha against reperfusion arrhythmias after global no-flow ischemia in the rat heart. Basic Res. Cardiol. 94, 71-77.
5. Amaro, A., Gude, F., González Juanatey, R., Iglesias, C., Fernández-Vazquez, F., García-Acuña, J., Gil, M., 1995. Plasma leukocyte elastase concentration in angiographically diagnosed coronary artery disease. Eur. Heart J. 16, 615-622.
6. Asgary, S., Naderi, G.H., Sadeghi, M., Kelishadi, R., Amiri, M., 2004. Antihypertensive effect of Iranian Crataegus curvisepala Lind.: a randomised double-blind study. Drugs Exp. Clin. Res. 30, 221-225.
7. Burstein, M., Scholnik, H.R., Morfin, R., 1970. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J. Lipid Res. 11, 583-595.
8. Caimi, G., Hoffman, E., Montana, M., Incalterra, E., Dispensa, F., D'Amico, T., Canino, B., Lo Presti, R., 2005. Plasmamarkers of platelet and polymorphonuclear leukocyte activation in young adults with acute myocardial infarction. Clin. Hemorheol. Microcirc. 32, 67-74.
9. Castilla, P., Echarri, R., Dávalos, A., Cerrato, F., Ortega, H., Teruel, J.L., Fernández, M., Gómez-Coronado, D., Ortuño, J., Lasunción, M.A., 2006. Concentrated red grape juice exerts antioxidant, hypolipidemic, and anti-inflammatory effects in both hemodialysis patients and healthy subjects. Am. J. Clin. Nutr. 84, 252-262.
10. Chatterjee, S.S., Koch, E., Jaggy, H., Krzeminsky, T., 1997. In vitro and in vivo studies on the cardioprotective action of oligomeric procyanidins in a Crataegus extract of leaves and blooms. Arzneimittelforschung 47, 821-825.
11. Chen, J.D., Wu, Y.Z., Tao, Z.L., Chen, Z.M., Liu, X.P., 1995. Hawthorn (shan zha) drink and its lowering effect on blood lipid levels in humans and rats. World Rev. Nutr. Diet 77, 147-154.
12. Dalli, E., Milara, J., Cortijo, J., Morcillo, E.J., Cosín-Sales, J., Sotillo, J.F., 2008. Hawthorn extract inhibit human isolated neutrophil functions. Pharmacol. Res. 57, 445-450.
13. De Smet, PA.G.M., 2002. Herbal remedies. N. Engl. J. Med. 347, 2046-2056.
14. Friedewald, W.T., Levy, R.I., Fredrickson, D.S., 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502.
15. Ginsburg, I., Mitra, R.S., Gibbs, D.F., Varani, J., Kohen, R., 1993. Killing of endothelial cells and release of arachidonic acid. Synergistic effects among hydrogen peroxide, membrane-damaging agents, cationic substances, and proteinases and their modulation by inhibitors. Inflammation 17, 295-319.
16. Holt, R.R., Lazarus, S.A., Sullards, M.C., Zhu, Q.Y., Schramm, D.D., Hammerstone, J.F., Fraga, C.G., Schmitz, H.H., Keen, C.L., 2002. Procyanidin dimer B2 [epicatechin-(4beta-8)-epicatechin] in human plasma after the consumption of a flavanol-rich cocoa. Am. J. Clin. Nutr. 76, 798-804.
17. Holubarsch, C.J.F., Colucci, W.S., Meinertz, T., Gaus, W., Tendera, M., 2008. The efficacy and safety of Crataegus extract WS® 1442 in patients with heart failure: the SPICE trial. Eur. J. Heart Fail. 10, 1255-1263.
18. Houard, X., Leclercq, A., Fontaine, V., Coutard, M., Martin-Ventura, J.L., Ho-Tin-Noé, B., Touat, Z., Meilhac, O., Michel, J.B., 2006. Retention and activation of blood-borne proteases in the arterial wall. J. Am Coll. Cardiol. 48, A3-A9.
19. 2005. JACC 46, 184-221.
20. Jayalakshmi, R., Thirupurasunduri, C.J., Devaraj, S.N., 2006. Pretreatment with alcoholic extract of Crataegus oxyacantha (AEC) activates mitochondrial protection during isoproterenol-induced myocardial infarction in rats. Mol. Cell. Biochem. 292, 59-67.
21. Joseph, G., Zhao, Y., Klaus, W., 1995. Pharmacologic action profile of Crataegus extract in comparison to epinephrine, amrinone, milrinone and digoxin in the isolated perfused guinea pig heart. Arzneimittelforschung 45, 1261-1265. (Pubitemid 26022260)
22. Kartnig, T., Kögl, G., Heydel, B., 1993. Production of flavonoids in cell cultures of Crataegus monogyna. Planta Med. 59, 537-538. (Pubitemid 24019544)
23. Kosuke, O., Kim, J.S., Rubin Bruce, K., 2007. Secretory phospholipases A2 stimulate mucus secretion, induce airway inflammation, and produce secretory hyperresponsiveness to neutrophil elastase in ferret trachea. Am. J. Physiol. Lung Cell. Mol. Physiol. 292, L62-L67.
24. Kyne, L., Hausdorff, J.M., Knight, E., Dukas, L., Azhar, G., Wei, J.Y., 2000. Neutrophilia and congestive heart failure after acute myocardial infarction. Am. Heart J. 139 (1 Pt 1), 94-100.
25. Owen, C.A., Campbell, E.J., 1999. The cell biology of leukocyte-mediated proteolysis. J. Leukoc. Biol. 65, 137-150.
26. La Cour, B., Molgaard, P., Yi, Z., 1995. Traditional Chinese medicine in treatment of hyperlipidaemia. J. Ethnopharmacol. 46, 125-129.
27. Leclercq, A., Houard, X., Philippe, M., Ollivier, V., Sebbag, U., Meilhac, O., Michel, J.B., 2007. Involvement of intraplaque haemorrhage in atherotrombosis via neutrophil protease enrichment. J. Leukoc. Biol. 82, 1420-1429.
28. Martin-Ventura, J.L., Leclercq, A., Blanco-Colio, L.M., Egido, J., Rossignol, P., Meilhac, O., Michel, J.B., 2007. Low plasma levels of HSP70 in patients with carotid atherosclerosis are associated with increased levels of proteolytic markers of neutrophil activation. Atherosclerosis 194, 334-341. (Pubitemid 47513095)
29. Miller, K.L., Liebowitz, R.S., Newby, L.K., Durham,M.H.S., 2004. Complementary and alternative medicine in cardiovascular disease: a review of biologically based approaches. Am. Heart J. 147, 401-411.
30. Naruko, T., Ueda, M., Haze, K., van del Wal, A., van der Loos, C.M., Itoh, A., Komatsu, R., Ikura, Y., Ogami, M., Shimada, Y., Ehara, S., Yoshiyama, M., Takeuchi, K., Yoshikawa, J., Becker, A.E., 2002. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106, 2894-2900. (Pubitemid 35424738)
31. Neukam, K., Stalh, W., Tronnier, H., Sies, H., Heinrich, U., 2007. Consumption of flavanol-rich cocoa acutely increases microcirculation in human skin. Eur. J. Nutr. 46, 53-56.
32. Oltra, A., Carbonell, F., Tormos, C., Iradi, A., Sáez, G.T., 2001. Antioxidant enzyme activities and the production of MDA and 8-oxo-DG in chronic lymphocytic leukaemia. Free Radic. Biol. Med. 30, 1286-1292.
33. Pham, C.T., 2006. Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 6, 541-550.
34. Pittler, M.H., Schmidt, K., Ernst, 2003. Hawthorn extract for treating heart failure: meta-analysis of randomized heart trials. Am. J. Med. 114, 665-674.
35. Piwowar, A., Knapik-Kordecka, M., Warwas, M., 2000. Concentration of leukocyte elastase in plasma and polymorphonuclear neutrophil extracts in type 2 diabetes. Clin. Chem. Lab. Med. 38, 1257-1261.
36. Pöpping, S., Rose, H., Ionescu, I., Fischer, Y., Kammermeier, H., 1995. Effect of hawthorn extract on contraction and energy turnover of isolated rat cardiomyocites. Arzneimittelforschung 45, 1157-1161.
37. Quettier-Deleu Voiselle, G., Fruchart, J.C., Duriez, P., Teissier, E., Bailleul, F., Vasseur, J., Trotin, F., 2003. Hawthorn extract inhibit LDL oxidation. Pharmazie 58, 577-581. (Pubitemid 37012241)
38. Rajendran, S., Deepalakshmi, P.D., Parasakthy, K., Devaraj, H., Devaraj, S.N., 1996. Effect of tincture of Crataegus on the LDL-receptor activity of plasma membrane of rats fed an atherogenic diet. Atherosclerosis 123, 235-241. (Pubitemid 26175078)
39. Rifai, N., Tracy, R.P., Ridker, P.M., 1999. Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin. Chem. 45, 2136-2141.
40. Rudolph, V., Rudolph, T.K., Hennings, J.Ch., Blankenberg, S., Schnabel, R., Steven, D., Haddad, M., Knittel, K., Wende, S., Wenzel, J., Münzel, T., Heitzer, T., Meinertz, T., Hübner Ch, Baldus, S., 2007. Activation of polymorphonuclear neutrophils in patients with impaired left ventricular function. Free Radic. Biol. Med. 43, 1189-1196.
41. Shahat, A.A., Hammouda, F., Ismail, S.I., Azzam, S.A., De Bruyne, T., Lasure, A., Van Poel, B., Pieters, L., Vlietinck, A.J., 1996. Anti-complementary activity of Crataegus sinaica. Planta Med. 62, 10-13. (Pubitemid 26056302)
42. Shamamian, P., Schwartz, J.D., Pocock, B., Monea, S., Whiting, D., Marcus, S.G., Mignatti, P., 2001. Activation of progelatinase (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J. Cell. Physiol. 189, 197-201.
43. Serruys, P.W., García-García, H.M., Buszman, P., Erne, P., Verheye, S., Aschermann, M., Duckers, H., Bleie, O., Dudek, D., 2008. Effects of the direct lipoprotein-associated phospholipase A2 inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 118, 1172-1182.
44. Spayd, R.W., Bruschi, B., Burdick, B.A., Dappen, G.M., Eikenberry, J.N., Esders, T.W., Figueras, J., Goodhue, C.T., LaRosa, D.D., Nelson, R.W., Rand, R.N., Wu, T.W., 1978. Multilayer film elements for clinical analysis. Clin. Chem. 24, 1348-1350.
45. Tauchert, M., 2002. Efficacy and safety of Crataegus extract WS 1442 in comparison with placebo in patients with chronic stableNewYork Heart Association class-III heart failure. Am. Heart J. 143, 910-915.
46. Tring, T.S., Hili, P., Naughton, D.P., 2009. Anti-collagenase, anti-elastase and anti-oxidant activities of extracts from 21 plants. BMC Complement. Altern. Med. 9, 27.
47. Tzoulaki, I., Murray, G.D., Lee, A.J., Rumley, A., Lowe, G., Fowkes, G., 2007. Relative value of inflammatory, haemostatic and rheological factors for incident myocardial infarction and stroke. The Edinburgh Artery Study. Circulation 115, 2119-2127. (Pubitemid 46659063)
48. Veveris, M., Koch, E., Chatterjee, S.S., 2004. Crataegus special extract WS® 1442 improves cardiac function and reduces infarct size in a rat model of prolonged coronary ischemia and reperfusion. Life Sci. 27, 1945-1955. (Pubitemid 38167562)
49. Walker, A.F., Marakis, G., Simpson, E., Hope, J.L., Morris, A.P., Robinson, P.A., Hassanein, M., Simpson, H.C., 2006. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial. Br. J. Gen. Pract. 56, 437-443.
50. Weikl, A., Assmus, K.D., Neukum-Schmidt, A., Schmitz, J., Zapfe jun, G., Noh, H.S., Siegrist, J., 1996. Crataegus special extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II). Fortschr. Med. 114, 291-296.
51. Wiedow, O., Meyer-Hoffert, U., 2005. Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J. Intern. Med. 257, 319-328.
52. Wong, S.H.Y., Knight, J.A., Hopfer, S.M., Zaharia, O., Leach Jr., C.N., Sunderman Jr., F.W., 1987. Lipoperoxides in plasma asmeasured by liquid-chromatography: separation of malondialdehyde-thiobarbituric acid adduct. Clin. Chem. 33, 214-220.
53. Wood, M.J., Stewart, R.L., Merry, H., Johnstone, D.E., Cox, J.L., 2003. Use of complementary and alternative medical therapies in patients with cardiovascular disease. Am. Heart J. 145, 806-812.
54. Zapfe jun, G., 2001. Clinical efficacy of Crataegus extract WS 1442 in congestive heart failure NYHA class II. Phytomedicine 8, 262-266.